Keywords: salix, swings, loss, 1st-qtr, pharmaceuticals, shares, dropped
Salix swings to loss in 1st-qtr 2008
Article | 19 May 2008
Salix Pharmaceuticals' shares dropped 7% to $6.43 on May 7, after the US drugmaker posted a first-quarter 2008 loss of $24.0 million, or $0.50 per diluted ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
